Keyphrases
Ewing Sarcoma
90%
Ewing Sarcoma Family of Tumors
51%
T Cells
41%
Bone Marrow Transplantation
32%
Granulocyte Colony-stimulating Factor (G-CSF)
29%
Interleukin-2
29%
Tumor
27%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
26%
Bone Marrow
18%
Transgenic
18%
Graft-versus-host Disease (GvHD)
18%
Event-free Survival
16%
EWS-FLI1
15%
Allogeneic Bone Marrow Transplantation
14%
Interleukin-10
14%
Malignancy
14%
T Cell Receptor
13%
Tumor Cells
12%
Pulmonary Alveolar Proteinosis
12%
Osteosarcoma
12%
Interleukin-6
11%
Tumor Patients
11%
Solid Tumors
11%
Pediatric Oncology
10%
Primitive Neuroectodermal Tumor
10%
Melphalan
10%
High Risk
10%
B Cells
9%
Overall Survival
9%
Childhood Cancer
9%
High Dose
9%
Clinical Course
9%
Risk Factors
9%
Capillary Leak Syndrome
9%
Metastasis
9%
Cyclosporine
9%
Neuroblastoma
9%
Etoposide
9%
Chondromodulin-1
9%
CD8+ T Cells
8%
Natural Killer Cells
8%
High-dose Chemotherapy
8%
HLA-A*02
8%
Poor Prognosis
8%
HLA Matching
8%
Acute Myeloid Leukemia
8%
Sarcoma Cells
8%
Aplastic Anemia
7%
Transplantation
7%
Targeted Therapy
7%
Medicine and Dentistry
Ewing Sarcoma
100%
Neoplasm
36%
T Cell
32%
Diseases
29%
Bone Marrow Transplantation
24%
Receptor
16%
Pediatrics
16%
Granulocyte Macrophage Colony Stimulating Factor
16%
Event Free Survival
15%
Childhood Cancer
15%
Metastatic Carcinoma
13%
Stem Cell
13%
Allogeneic Stem Cell Transplantation
12%
Cancer
12%
Interleukin 2
11%
Solid Malignant Neoplasm
11%
In Vitro
11%
Overall Survival
11%
Lung Alveolus Proteinosis
10%
Drug Megadose
10%
Ganglioneuroblastoma
10%
Melphalan
10%
Infection
10%
B Cell
10%
T Lymphocyte Receptor
9%
Lung
8%
High Dose Chemotherapy
8%
Immunotherapy
8%
Disease Course
8%
Cell Line
8%
Etoposide
8%
Personalized Medicine
8%
Radiation Therapy
8%
Cytotoxic T-Cell
7%
Targeted Therapy
7%
Tumor Cell
7%
Aplastic Anemia
7%
DNA Microarray
7%
Cytokine
7%
Connective Tissue Cancer
6%
Stem Cell Therapy
6%
HLA-A
6%
Whole Body Radiation
6%
Pediatrics Patient
6%
Gene Expression
6%
Differential Diagnosis
6%
Osteosarcoma
6%
Respiratory Failure
6%
Survival Rate
6%
Malignant Neoplasm
5%
Immunology and Microbiology
T Cell
56%
Interleukin 2
30%
Bone Marrow Transplantation
25%
Transgenics
24%
Immunotherapy
19%
Cytokine
17%
B Cell
16%
T Cell Receptor
15%
Granulocyte Macrophage Colony-Stimulating Factor
12%
Cell Line
12%
Tumor Cell
11%
Drug Megadose
10%
Cytotoxic T-Cell
10%
Stem Cell
10%
Myeloid
10%
Allogeneic Stem Cell Transplantation
10%
Capillary
9%
Graft-Versus-Host Disease
9%
Allogeneic Bone Marrow Transplantation
9%
Interleukin 10
8%
Peptides
8%
Interleukin 6
8%
Dendritic Cell
7%
Aplastic Anemia
7%
Interleukin 7
7%
Engraftment
7%
Tumor Cell Line
6%
Event Free Survival
6%
Cytotoxic T Cell
6%
Tumor Antigen
6%
T-Helper Cell
6%
Gene Expression
6%
Programmed Cell Death
6%
CD3 Antigen
6%
T Cell Activation
5%
Cell Function
5%
Epithelial Membrane Antigen
5%
Asthma
5%
Cyclophosphamide
5%
Acute Graft Versus Host Disease
5%
Natural Killer Cell
5%
Fibroblast
5%
Tumor Necrosis Factor
5%
Complement Activation
5%
Overall Survival
5%
